Open Access

Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity

  • Authors:
    • Mitsuyo Yoshida
    • Ayumi Taguchi
    • Kei Kawana
    • Juri Ogishima
    • Katsuyuki Adachi
    • Akira Kawata
    • Hiroe Nakamura
    • Masakazu Sato
    • Asaha Fujimoto
    • Tomoko Inoue
    • Kensuke Tomio
    • Mayuyo Mori
    • Takeshi Nagamatsu
    • Takahide Arimoto
    • Kaori Koga
    • Osamu Wada Hiraike
    • Katsutoshi Oda
    • Tohru Kiyono
    • Yutaka Osuga
    • Tomoyuki Fujii
  • View Affiliations

  • Published online on: July 26, 2018     https://doi.org/10.3892/ijo.2018.4504
  • Pages: 1580-1590
  • Copyright: © Yoshida et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Increased neutrophil counts are a hallmark of a poor prognosis for cancer. We previously reported that KRAS promoted tumorigenesis and increased neutrophil counts in a mouse peritoneal cancer model. In the current study, we evaluated the role of increased neutrophils in cancer progression, as well as their influence on the intraperitoneal microenvironment. A mouse peritoneal cancer model was established using the KRAS-transduced mouse ovarian cancer cell line, ID8-KRAS. Neutrophil function was assessed by neutrophil depletion in ID8-KRAS mice. Neutrophil depletion markedly accelerated tumor formation; this was accompanied by an increase in interleukin-6 concentrations in ascites. Neutrophil depletion significantly decreased the amount of local and systemic CD8+ T cells, while increasing the amount of local CD4+ T cells, accompanied by an increased amount of monocytic myeloid-derived suppressor cells (M-MDSCs) and regulatory T cells (Tregs) (P<0.05). The roles of peritoneal neutrophils (PENs) in CD8+ T cell activation were assessed in vitro. PENs of ID8-KRAS mice had a strong potential to enhance T cell proliferation with a higher expression of the T cell costimulatory molecules OX40 ligand (OX40L) and 4-1BB ligand (4-1BBL), as compared with peripheral blood neutrophils (PBNs). These findings suggest that neutrophils recruited into the KRAS-induced tumor microenvironment (TME) have antitumor properties with the potential to modulate the numbers of M-MDSCs and Tregs and activate CD8+ T cells through T cell costimulatory molecules.

References

1 

Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, Scherag A, Hütte J, Dominas N, Lehnerdt GF, et al: Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 129:2183–2193. 2011. View Article : Google Scholar

2 

Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F and von der Maase H: Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol. 27:4709–4717. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Jensen TO, Schmidt H, Møller HJ, Donskov F, Høyer M, Sjoegren P, Christensen IJ and Steiniche T: Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer. 118:2476–2485. 2012. View Article : Google Scholar

4 

Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. J Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI

5 

Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, et al: Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study. Int J Urol. 22:638–643. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Nakamura K, Nagasaka T, Nishida T, Haruma T, Ogawa C, Kusumoto T, Seki N and Hiramatsu Y: Neutrophil to lymphocyte ratio in the pre-treatment phase of final-line chemotherapy predicts the outcome of patients with recurrent ovarian cancer. Oncol Lett. 11:3975–3981. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W and Wu X: Preoperative neutrophil-to-lymphocyte ratio as a predictive and prognostic factor for high-grade serous ovarian cancer. PLoS One. 11:e01561012016. View Article : Google Scholar : PubMed/NCBI

8 

Yoshida M, Taguchi A, Kawana K, Adachi K, Kawata A, Ogishima J, Nakamura H, Fujimoto A, Sato M, Inoue T, et al: Modification of the tumor microenvironment in KRAS or c-MYC-induced ovarian cancer-associated peritonitis. PLoS One. 11:e01603302016. View Article : Google Scholar : PubMed/NCBI

9 

Chandler RL, Damrauer JS, Raab JR, Schisler JC, Wilkerson MD, Didion JP, Starmer J, Serber D, Yee D, Xiong J, et al: Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun. 6:61182015. View Article : Google Scholar : PubMed/NCBI

10 

Eser S, Schnieke A, Schneider G and Saur D: Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer. 111:817–822. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Pylayeva-Gupta Y, Grabocka E and Bar-Sagi D: RAS oncogenes: Weaving a tumorigenic web. Nat Rev Cancer. 11:761–774. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S, Cruz-Monserrate Z, Wang H, Ji B and Logsdon CD: An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest. 122:1519–1528. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L and Inferrera C: Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol. 15:831–837. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Jablonska J, Leschner S, Westphal K, Lienenklaus S and Weiss S: Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest. 120:1151–1164. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of tumor-associated neutrophil phenotype by TGF-beta: 'N1' versus "N2" TAN. Cancer Cell. 16:183–194. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS and Xu YF: Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol. 54:497–505. 2011. View Article : Google Scholar

17 

Houghton AM: The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances. Cell Cycle. 9:1732–1737. 2010. View Article : Google Scholar

18 

Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock WW, et al: Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest. 124:5466–5480. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H and Kiyono T: Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis. 30:423–431. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Overmyer KA, Thonusin C, Qi NR, Burant CF and Evans CR: Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: Studies in a C57BL/6J mouse model. PLoS One. 10:e01172322015. View Article : Google Scholar : PubMed/NCBI

21 

Arnold L, Tyagi RK, Mejia P, Van Rooijen N, Pérignon JL and Druilhe P: Analysis of innate defences against Plasmodium falciparum in immunodeficient mice. Malar J. 9:1972010. View Article : Google Scholar : PubMed/NCBI

22 

Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ and Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol. 167:39–45. 2005. View Article : Google Scholar

23 

Tempfer C, Zeisler H, Sliutz G, Haeusler G, Hanzal E and Kainz C: Serum evaluation of interleukin 6 in ovarian cancer patients. Gynecol Oncol. 66:27–30. 1997. View Article : Google Scholar : PubMed/NCBI

24 

Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C and Mancuso S: Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer. 71:354–356. 1995. View Article : Google Scholar : PubMed/NCBI

25 

Wang J, Yang L, Yu L, Wang YY, Chen R, Qian J, Hong ZP and Su XS: Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer. Oncotarget. 8:17050–17058. 2017.PubMed/NCBI

26 

O'Connor MA, Vella JL and Green WR: Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency. J Gen Virol. 97:509–522. 2016. View Article : Google Scholar

27 

Idorn M, Køllgaard T, Kongsted P, Sengeløv L and Thor Straten P: Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer. Cancer Immunol Immunother. 63:1177–1187. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Rao HL, Chen JW, Li M, Xiao YB, Fu J, Zeng YX, Cai MY and Xie D: Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS One. 7:e308062012. View Article : Google Scholar : PubMed/NCBI

29 

Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 73:215–220. 2007. View Article : Google Scholar

30 

Nuhn P, Vaghasia AM, Goyal J, Zhou XC, Carducci MA, Eisenberger MA and Antonarakis ES: Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel. BJU Int. 114(6b): E11–E17. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T and Widmann WD: Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 19:217–224. 2012. View Article : Google Scholar

32 

Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P and Van Ginderachter JA: Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 111:4233–4244. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Youn JI, Nagaraj S, Collazo M and Gabrilovich DI: Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 181:5791–5802. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S and Bronte V: Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci. 1319:47–65. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Chen MF, Kuan FC, Yen TC, Lu MS, Lin PY, Chung YH, Chen WC and Lee KD: IL-6-stimulated CD11b+ CD14+ HLA-DR myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget. 5:8716–8728. 2014.PubMed/NCBI

36 

Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM, Heyworth PG, Efron PA and Moldawer LL: A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med. 17:281–292. 2011. View Article : Google Scholar :

37 

Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, et al: Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol. 40:22–35. 2010. View Article : Google Scholar

38 

Haverkamp JM, Smith AM, Weinlich R, Dillon CP, Qualls JE, Neale G, Koss B, Kim Y, Bronte V, Herold MJ, et al: Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. Immunity. 41:947–959. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Umemura N, Saio M, Suwa T, Kitoh Y, Bai J, Nonaka K, Ouyang GF, Okada M, Balazs M, Adany R, et al: Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol. 83:1136–1144. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Sumida K, Wakita D, Narita Y, Masuko K, Terada S, Watanabe K, Satoh T, Kitamura H and Nishimura T: Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses. Eur J Immunol. 42:2060–2072. 2012. View Article : Google Scholar : PubMed/NCBI

41 

Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G and Wahl SM: Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 198:1875–1886. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2018
Volume 53 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yoshida, M., Taguchi, A., Kawana, K., Ogishima, J., Adachi, K., Kawata, A. ... Fujii, T. (2018). Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity. International Journal of Oncology, 53, 1580-1590. https://doi.org/10.3892/ijo.2018.4504
MLA
Yoshida, M., Taguchi, A., Kawana, K., Ogishima, J., Adachi, K., Kawata, A., Nakamura, H., Sato, M., Fujimoto, A., Inoue, T., Tomio, K., Mori, M., Nagamatsu, T., Arimoto, T., Koga, K., Hiraike, O. W., Oda, K., Kiyono, T., Osuga, Y., Fujii, T."Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity". International Journal of Oncology 53.4 (2018): 1580-1590.
Chicago
Yoshida, M., Taguchi, A., Kawana, K., Ogishima, J., Adachi, K., Kawata, A., Nakamura, H., Sato, M., Fujimoto, A., Inoue, T., Tomio, K., Mori, M., Nagamatsu, T., Arimoto, T., Koga, K., Hiraike, O. W., Oda, K., Kiyono, T., Osuga, Y., Fujii, T."Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity". International Journal of Oncology 53, no. 4 (2018): 1580-1590. https://doi.org/10.3892/ijo.2018.4504